retatrutide versus tirzepatide vs for weight loss What Is Retatrutide vs Tirzepatide?
Description
December 5, 2025
Compounding pharmacies will be allowed to continue to compound tirzepatide for now, but it remains to be seen how long they will be able to do so and if they will be able to continue to do so by adding additional ingredients to differentiate their product from the non-compounded, non-approved version
Expert answers to our most frequently asked questions Tirzepatide is a dual GIP/GLP-1 receptor agonist that simultaneously targets two key hormones
The new GIP receptor stimulus restarts metabolic pathways that had adapted to pure GLP-1 agonism
Long-term dosing considerations Both compounds are intended for long-term use
